BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17369141)

  • 1. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.
    Smith JR; Falkenhagen KM; Coupland SE; Chipps TJ; Rosenbaum JT; Braziel RM
    Am J Clin Pathol; 2007 Apr; 127(4):633-41. PubMed ID: 17369141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and application of chemokine CXCL13 in central nervous system lymphoma.
    Li C; Zhang L; Jin Q; Jiang H; Wu C
    Ann Hematol; 2023 Nov; ():. PubMed ID: 38010409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4, CXCR5 and CD44 May Be Involved in Homing of Lymphoma Cells into the Eye in a Patient Derived Xenograft Homing Mouse Model for Primary Vitreoretinal Lymphoma.
    Babst N; Isbell LK; Rommel F; Tura A; Ranjbar M; Grisanti S; Tschuch C; Schueler J; Doostkam S; Reinacher PC; Duyster J; Kakkassery V; von Bubnoff N
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus and Neurological Diseases.
    Zhang N; Zuo Y; Jiang L; Peng Y; Huang X; Zuo L
    Front Mol Biosci; 2021; 8():816098. PubMed ID: 35083281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.
    Soldan SS; Su C; Lamontagne RJ; Grams N; Lu F; Zhang Y; Gesualdi JD; Frase DM; Tolvinski LE; Martin K; Messick TE; Fingerut JT; Koltsova E; Kossenkov A; Lieberman PM
    PLoS Pathog; 2021 Jun; 17(6):e1009618. PubMed ID: 34106998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Infection in the Development of Neurological Disorders.
    Soldan SS; Lieberman PM
    Drug Discov Today Dis Models; 2020; 32(Pt A):35-52. PubMed ID: 33897799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.
    Belhouachi N; Xochelli A; Boudjoghra M; Lesty C; Cassoux N; Fardeau C; Tran THC; Choquet S; Sarker B; Houillier C; Alentorn A; LeHoang P; Soussain C; Touitou V; Merle-Beral H; Hoang-Xuan K; Bodaghi B; Stamatopoulos K; Davi F
    Blood Adv; 2020 Apr; 4(7):1357-1366. PubMed ID: 32267931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives.
    Zhang H; Maeda M; Shindo M; Ko M; Mane M; Grommes C; Weber W; Blasberg R
    Mol Imaging Biol; 2020 Oct; 22(5):1184-1196. PubMed ID: 32239371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenge of Primary Central Nervous System Lymphoma.
    Carnevale J; Rubenstein JL
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1293-1316. PubMed ID: 27888882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular Lymphoma Models.
    Aronow ME; Shen D; Hochman J; Chan CC
    Ocul Oncol Pathol; 2015 Apr; 1(3):214-22. PubMed ID: 27171354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches in primary central nervous system lymphoma.
    Fraser E; Gruenberg K; Rubenstein JL
    Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intricate role of CXCR4 in cancer.
    Chatterjee S; Behnam Azad B; Nimmagadda S
    Adv Cancer Res; 2014; 124():31-82. PubMed ID: 25287686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in central nervous system lymphomas.
    Wang CC; Carnevale J; Rubenstein JL
    Br J Haematol; 2014 Aug; 166(3):311-25. PubMed ID: 24837460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.
    Ponzoni M; Issa S; Batchelor TT; Rubenstein JL
    Ann Oncol; 2014 Feb; 25(2):316-22. PubMed ID: 24265352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I treat CNS lymphomas.
    Rubenstein JL; Gupta NK; Mannis GN; Lamarre AK; Treseler P
    Blood; 2013 Oct; 122(14):2318-30. PubMed ID: 23963042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
    Rubenstein JL; Wong VS; Kadoch C; Gao HX; Barajas R; Chen L; Josephson SA; Scott B; Douglas V; Maiti M; Kaplan LD; Treseler PA; Cha S; Hwang JH; Cinque P; Cyster JG; Lowell C
    Blood; 2013 Jun; 121(23):4740-8. PubMed ID: 23570798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells.
    Appukuttan B; McFarland TJ; Stempel A; Kassem JB; Hartzell M; Zhang Y; Bond D; West K; Wilson R; Stout A; Pan Y; Ilias H; Robertson K; Klein ML; Wilson D; Smith JR; Stout JT
    PLoS One; 2012; 7(6):e31260. PubMed ID: 22761647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
    Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
    Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV tropism and decreased risk of breast cancer.
    Hessol NA; Napolitano LA; Smith D; Lie Y; Levine A; Young M; Cohen M; Minkoff H; Anastos K; D'Souza G; Greenblatt RM; Goedert JJ
    PLoS One; 2010 Dec; 5(12):e14349. PubMed ID: 21179547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.